MM
Melissa Mathias
Credentials: ·
History
- 2011–2014
Residency
- 2007–2011
Medical School
Research
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma
New England Journal of Medicine · 2018 · 1,114 citations
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
New England Journal of Medicine · 2022 · 277 citations
A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens
Journal of Clinical Investigation · 2017 · 75 citations
- IL
5 papers
- MF
5 papers
- DS
3 papers
3 papers
- KP
3 papers
- NK
3 papers
- QZ
3 papers
- AC
2 papers
